BETHANY SABINS: Open Payments
NPI 1194065797 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 7 payments from 4 companies in 2025. Trend: 2023 $412 · 2024 $247 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Myriad Genetic Laboratories, Inc. | 3 | $71 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| ABBVIE INC. | 1 | $19 |
Products named: LYNPARZA, MYRISK, JEMPERLI, ELAHERE.
Industry payments across MS — which companies pay providers there.
